Capecitabine

Sold as Xeloda, Capecitabine cipla, Capeloda, Eurobeen, Capecitabine eurolab, Caxeta, Pecaset, Capexa, Zelbeen, Capecitabine specpharm, Auroxeda, Rebutrix, Etoposide adco, Tanicep, Binecap, Captero, Capcituras

S4Read from the PI-PIL document and verified

C₁₅H₂₂FN₃O₆359.35 g/mol

Pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate

Drag to rotate. Structure from PubChem CID 60953.

Loading Wikipedia summary

Registration

Applicants: 10
Registrations: 32
Schedule source: SAHPRA documentation

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Equity Pharmaceutical (Pty) LtdCertificate held by Equity Pharmaceuticals (Pty) Ltd.	Xeloda	150, 500	330198, 330199	S4	PI PIL
Cipla Medpro (Pty) LtdCertificate held by Cipla Medpro Pty (Ltd)2 of 4 cancelled	Capecitabine cipla, Capeloda	150, 150 / 500 mg, 500	470361, 470362, 470363, 470364	S4	PI PIL
Eurolab (Pty) Ltd2 of 8 cancelled	Eurobeen, Capecitabine eurolab, Pecaset, Zelbeen	50, 150mg, 500 mg	470805, 470806, 470807, 470808, 490681, 490682, 490804, 490805	S4	None
Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd	Caxeta	100 mg / 500 mg	471287, 471288	S4	PI PIL
Accord Healthcare (Pty) Ltd	Capexa	150mg, 500mg	490683, 490684	S4	None
Specpharm (Pty) Ltd	Capecitabine specpharm	150, 500	491045, 491046	S4	None
Aurogen South Africa (Pty) Ltd	Auroxeda, Rebutrix	150 mg, 500 mg	530100, 530101, 530102	S4	None
Adcock Ingram Critical Care (Pty) Ltd	Etoposide adco	100 mg/5 ml	530103	S4	None
Hetero Drugs South Africa (Pty) Ltd	Tanicep, Binecap, Captero	150mg, 500	540265, 540266.265, 540267.265, 550423, 550424.423, 550425.423	S4	PI PIL
Alturas Healthcare (Pty) Ltd	Capcituras	150 mg, 500 mg	570293, 570294	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Xeloda 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150Tablet	33019833/26/0198Approved 30 September 2024	Registered	S4	PI PIL
Xeloda 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg	500Tablet	33019933/26/0199Approved 30 September 2024	Registered	S4	PI PIL
Capecitabine cipla 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150	47036147/26/0361	Cancelled	S4	None
Capecitabine cipla 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg	500	47036247/26/0362	Cancelled	S4	None
Capeloda 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150 / 500 mgFilm-coated tablets	47036347/26/0363Approved 26 June 2019	Registered	S4	PI PIL
Capeloda 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg	150 / 500 mgFilm-coated tablets	47036447/26/0364Approved 26 June 2019	Registered	S4	PI PIL
Eurobeen 150 EACH TABLET CONTAINS: CAPECITABINE 150,0 mg	150	47080547/26/0805	Registered	S4	None
Eurobeen 50 EACH TABLET CONTAINS: CAPECITABINE 500,0 mg	50	47080647/26/0806	Registered	S4	None
Capecitabine 150 eurolab EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150	47080747/26/0807	Cancelled	S4	None
Capecitabine 500 eurolab EACH TABLET CONTAINS CAPECITABINE 500,0 mg	500	47080847/26/0808	Cancelled	S4	None
Caxeta 150 Each Tablet contains: Capecitabine 150,0 mg	100 mg / 500 mgFilm-coated tablets.	47128747/26/1287Approved 17 February 2026	Registered	S4	PI PIL
Caxeta 500 Each Tablet contains: Capecitabine 500,0 mg	100 mg / 500 mgFilm-coated tablets.	47128847/26/1288Approved 17 February 2026	Registered	S4	PI PIL
Pecaset 150mg EACH TABLET CONTAINS : CAPECITABINE 150,0 mg	150mg	49068149/26/0681	Registered	S4	None
Pecaset 500 MG EACH TABLET CONTAINS : CAPECITABINE 500,0 mg	500 mg	49068249/26/0682	Registered	S4	None
Capexa 150mg EACH TABLET CONTAINS :CAPECITABINE 150,0 mg	150mg	49068349/26/0683	Registered	S4	None
Capexa 500mg EACH TABLET CONTAINS :CAPECITABINE 500,0 mg	500mg	49068449/26/0684	Registered	S4	None
Zelbeen 150 EACH TABLET CONTAINS: CAPECITABINE 150,0 mg	150	49080449/26/0804	Registered	S4	None
Zelbeen 50 EACH TABLET CONTAINS: CAPECITABINE 500,0 mg	50	49080549/26/0805	Registered	S4	None
Capecitabine specpharm 150 EACH TABLET CONTAINS : CAPECITABINE 150,0 mg	150	49104549/26/1045	Registered	S4	None
Capecitabine specpharm 500 EACH TABLET CONTAINS : CAPECITABINE 500,0 mg	500	49104649/26/1046	Registered	S4	None
Auroxeda 150 MG EACH FILM-COATED TABLET CONTAINS CAPECITABINE 150,0 mg	150 mg	53010053/26/0100	Registered	S4	None
Auroxeda 500 MG EACH FILM-COATED TABLET CONTAINS CAPECITABINE 500,0 mg	500 mg	53010153/26/0101	Registered	S4	None
Rebutrix 150 MG EACH FILM-COATED TABLET CONTAINS CAPECITABINE 150,0 mg	150 mg	53010253/26/0102	Registered	S4	None
Etoposide 100 mg/5 ML adco EACH FILM-COATED TABLET CONTAINS CAPECITABINE 500,0 mg	100 mg/5 ml	53010353/26/0103	Registered	S4	None
Tanicep 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg	500Film-coated tablets	54026554/26/0265Approved 13 March 2021	Registered	S4	PI PIL
Binecap 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg	500Film-coated tablets	540266.26554/26/0266.265Approved 13 March 2021	Registered	S4	PI PIL
Captero 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg	500Film-coated tablets	540267.26554/26/0267.265Approved 13 March 2021	Registered	S4	PI PIL
Tanicep 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150mgTablet	55042355/26/0423Approved 12 October 2021	Registered	S4	PI PIL
Binecap 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150mgTablet	550424.42355/26/0424.423Approved 12 October 2021	Registered	S4	PI PIL
Captero 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg	150mgTablet	550425.42355/26/0425.423Approved 12 October 2021	Registered	S4	PI PIL
Capcituras 150 MG EACH TABLET CONTAINS: CAPECITABINE 150,0 mg	150 mg	57029357/26/0293	Registered	S4	None
Capcituras 500 MG EACH TABLET CONTAINS: CAPECITABINE 500,0 mg	500 mg	57029457/26/0294	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Capecitabine

S4: Capecitabine
Consolidated Schedules 06 July 2026, line 5647

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Xeloda 150, Equity Pharmaceutical (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsXeloda 150, Equity Pharmaceutical (Pty) Ltd Patient information leaflet (PIL)For patients and carersXeloda 150, Equity Pharmaceutical (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background